Drug Search Results
More Filters [+]

Trimegestone

Alternative Names: trimegestone
Latest Update: 2021-06-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Vaginal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Ireland | Italy | Peru | Portugal | Sweden

Approved Indications: None

Known Adverse Events: None

Company: Evestra
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trimegestone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Menopause

Phase 2: Contraception

Phase 1: Pregnancy Outcomes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Ovulation inhibition study with trimegestone

P2

Completed

Contraception

2019-04-05

GDN 012/17

P1

Completed

Pregnancy Outcomes

2018-01-12

0753T-101538

P4

Completed

Menopause

None

Recent News Events